These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 9701364

  • 1. Antisense c-myc and immunostimulatory oligonucleotide inhibition of tumorigenesis in a murine B-cell lymphoma transplant model.
    Smith JB, Wickstrom E.
    J Natl Cancer Inst; 1998 Aug 05; 90(15):1146-54. PubMed ID: 9701364
    [Abstract] [Full Text] [Related]

  • 2. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
    Leonetti C, D'Agnano I, Lozupone F, Valentini A, Geiser T, Zon G, Calabretta B, Citro G C, Zupi G.
    J Natl Cancer Inst; 1996 Apr 03; 88(7):419-29. PubMed ID: 8618233
    [Abstract] [Full Text] [Related]

  • 3. Prevention of tumor formation in a mouse model of Burkitt's lymphoma by 6 weeks of treatment with anti-c-myc DNA phosphorothioate.
    Huang Y, Snyder R, Kligshteyn M, Wickstrom E.
    Mol Med; 1995 Sep 03; 1(6):647-58. PubMed ID: 8529131
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of tumorigenesis in a murine B-cell lymphoma transplant model by c-Myc complementary oligonucleotides.
    Smith JB, Wickstrom E.
    Adv Exp Med Biol; 1998 Sep 03; 451():17-22. PubMed ID: 10026844
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A combination treatment of c-myc antisense DNA with all-trans-retinoic acid inhibits cell proliferation by downregulating c-myc expression in small cell lung cancer.
    Akie K, Dosaka-Akita H, Murakami A, Kawakami Y.
    Antisense Nucleic Acid Drug Dev; 2000 Aug 03; 10(4):243-9. PubMed ID: 10984118
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neuroblastoma.
    Burkhart CA, Cheng AJ, Madafiglio J, Kavallaris M, Mili M, Marshall GM, Weiss WA, Khachigian LM, Norris MD, Haber M.
    J Natl Cancer Inst; 2003 Sep 17; 95(18):1394-403. PubMed ID: 13130115
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cationic lipids reduce time and dose of c-myc antisense oligodeoxynucleotides required to specifically inhibit Burkitt's lymphoma cell growth.
    Williams SA, Chang L, Buzby JS, Suen Y, Cairo MS.
    Leukemia; 1996 Dec 17; 10(12):1980-9. PubMed ID: 8946941
    [Abstract] [Full Text] [Related]

  • 13. c-myc antisense oligonucleotide treatment ameliorates murine ARPKD.
    Ricker JL, Mata JE, Iversen PL, Gattone VH.
    Kidney Int; 2002 Jan 17; 61(1 Suppl):S125-31. PubMed ID: 11841626
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. c-MYC antisense phosphosphorodiamidate morpholino oligomer inhibits lung metastasis in a murine tumor model.
    Sekhon HS, London CA, Sekhon M, Iversen PL, Devi GR.
    Lung Cancer; 2008 Jun 17; 60(3):347-54. PubMed ID: 18096271
    [Abstract] [Full Text] [Related]

  • 18. Tumor regression by combination antisense therapy against Plk1 and Bcl-2.
    Elez R, Piiper A, Kronenberger B, Kock M, Brendel M, Hermann E, Pliquett U, Neumann E, Zeuzem S.
    Oncogene; 2003 Jan 09; 22(1):69-80. PubMed ID: 12527909
    [Abstract] [Full Text] [Related]

  • 19. Phosphorothioated antisense c-myc oligonucleotide inhibits the growth of human colon carcinoma cells.
    Yu BW, Nguyen D, Anderson S, Allegra CA.
    Anticancer Res; 1997 Jan 09; 17(6D):4407-13. PubMed ID: 9494542
    [Abstract] [Full Text] [Related]

  • 20. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.
    Zupi G, Scarsella M, Semple SC, Mottolese M, Natali PG, Leonetti C.
    Clin Cancer Res; 2005 Mar 01; 11(5):1990-8. PubMed ID: 15756025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.